Latest News in the pharma Industry

All

Lilly backs Nektar Therapeutics' novel immunological therapy

Lilly backs Nektar Therapeutics' novel immunological therapy

24 Jul 2017

NKTR-358 has the potential to treat a number of autoimmune and other chronic inflammatory conditions.

Read more 
Novartis receives positive CHMP opinion for Rydapt

Novartis receives positive CHMP opinion for Rydapt

23 Jul 2017

If approved, Rydapt would represent the first targeted treatment for newly diagnosed FLT3-mutated AML in the EU.

Read more 
GSK receives FDA approval for a new self-injectable formulation of Benlysta

GSK receives FDA approval for a new self-injectable formulation of Benlysta

23 Jul 2017

The approval marks the first subcutaneous self-injection treatment option for patients with systemic lupus erythematosus.

Read more 
Boehringer Ingelheim breaks ground on $217 million expansion of Fremont, California manufacturing facility

Boehringer Ingelheim breaks ground on $217 million expansion of Fremont, California manufacturing facility

23 Jul 2017

Expansion will triple capacity, add nearly 300 new jobs.

Read more 
Merck and Pfizer collaborate with Corning to modernize pharmaceutical glass packaging

Merck and Pfizer collaborate with Corning to modernize pharmaceutical glass packaging

23 Jul 2017

Collaborations result in development of Corning Valor Glass.

Read more 
Recipharm and LIDDS establish industrial manufacturing capabilities for a novel prostate cancer product

Recipharm and LIDDS establish industrial manufacturing capabilities for a novel prostate cancer product

20 Jul 2017

GMP Manufacturing line industrialised according to a unique process invented by LIDDS, involving the installation of novel equipment that is new to the pharmaceutical industry.

Read more 
Catalent and academia on quest to better understand pediatric drug formulation and delivery challenges

Catalent and academia on quest to better understand pediatric drug formulation and delivery challenges

20 Jul 2017

Goal of the collaboration is to identify therapies and diseases for which there is a high need for pediatric-friendly formulations.

Read more 
LifeArc negotiates exclusive licence deal with Nemysis for oral iron supplement technology

LifeArc negotiates exclusive licence deal with Nemysis for oral iron supplement technology

20 Jul 2017

IHAT, a novel synthetic material, is a commercially viable alternative to ferrous salts for iron supplementation.

Read more 
Positive results from 12-month Phase III safety study of Revefenacin in patients with COPD

Positive results from 12-month Phase III safety study of Revefenacin in patients with COPD

20 Jul 2017

These data, combined with positive results from two Phase III efficacy studies, support NDA filing planned for fourth quarter of 2017.

Read more 
Onyx helps to accelerate TopiVert’s compounds to clinic

Onyx helps to accelerate TopiVert’s compounds to clinic

19 Jul 2017

With support from the CRO, TopiVert has been able to accelerate scale-up and produce GMP batches, which are now being used in clinical trials.

Read more 
GSK delivers double-edged sword

GSK delivers double-edged sword

19 Jul 2017

Company announces investments, the sale of several products and a proposal to close a UK manufacturing site.

Read more 
South Korean pharma rapidly becoming manufacturing export hub

South Korean pharma rapidly becoming manufacturing export hub

19 Jul 2017

Overseas buyers at CPhI Korea double in the past 2 years.

Read more